Profile
BSX-PA ABT BSX SYK MDT EW
Company Name Boston Scientific Corporation Abbott Laboratories Boston Scientific Corporation Stryker Corporation Medtronic plc Edwards Lifesciences Corporation
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Medical - Devices Medical - Devices Medical - Devices Medical - Devices Medical - Devices Medical - Devices
Market Cap $175.45B $230.05B $159.33B $148.97B $118.20B $47.69B
Employees 45.00K 114.00K 53.00K 53.00K 95.00K 15.80K
CEO Michael F. Mahoney Robert B. Ford Michael F. Mahoney Kevin A. Lobo Geoffrey Straub Martha Bernard J. Zovighian
Ratings
BSX-PA ABT BSX SYK MDT EW
Quant Rating Score 4 1 3 3 4
Quant Rating Buy Strong Sell Neutral Neutral Buy
Trading
BSX-PA ABT BSX SYK MDT EW
Last Close $122.18 $132.18 $107.53 $388.56 $92.25 $81.22
High 52 $122.18 $140.22 $107.76 $403.53 $94.5 $81.83
Low 52 $122.18 $111.1 $81.37 $337.28 $79.61 $64.54
Price vs. 52 Week High 0 % -5.73 % -0.21 % -3.71 % -2.38 % -0.75 %
Price vs. 52 Week Low 0 % 18.97 % 32.15 % 15.2 % 15.88 % 25.84 %
Total Return
BSX-PA ABT BSX SYK MDT EW
1 Month Return 0 % 1.73 % 0.69 % 1.85 % 2.91 % 1.41 %
3 Month Return 0 % -0.59 % 4.98 % 1.56 % 7.77 % 4.3 %
6 Month Return 0 % -3.92 % 3.78 % -0.35 % -0.84 % 13.79 %
9 Month Return 0 % 13.98 % 18.37 % -0.31 % 8.12 % 9.46 %
YTD Return 0 % 16.86 % 20.39 % 7.92 % 15.49 % 9.71 %
1 Year Return 0 % 15.54 % 31.2 % 7.84 % 1.34 % 17.83 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
BSX-PA ABT BSX SYK MDT EW
Dividend Yield Percentage (TTM) - 1.76 % - 0.85 % 3.05 % -
Dividend Paid and Capex Coverage Ration (TTM) 3.96 % 1.45 % 3.96 % 2.2 % 1.31 % 4.25 %
Dividend Per Share (TTM) - 2.32 % - 3.32 % 2.81 % -
Payout Ratio (TTM) 0.92 % 28.42 % 0.92 % 42.32 % 77.26 % -
Growth
BSX-PA ABT BSX SYK MDT EW
Asset Growth 12.12 % 11.2 % 12.12 % 1.89 %
Gross Profit Growth 16.26 % 6.43 % 16.26 % 3.58 %
Revenue Growth 17.61 % 4.59 % 17.61 % 3.62 %
Revenue 3 Year 36.16 % -0.18 % 36.16 % 10.52 %
Revenue 5 Year 47.52 % 34.24 % 47.52 % 20.96 %
Revenue 10 Year 104.22 % 80.43 % 104.22 % 41.05 %
EBIT Growth 18.25 % 3.45 % 18.25 % 14.42 %
Net Income Growth 16.38 % 134.18 % 16.38 % 26.82 %
Net Income 3 Yeari Growth Per Share 72.31 % 94.27 % 72.31 % -3.39 %
Net Income 5 Yeari Growth Per Share -62.7 % 271.11 % -62.7 % 1.52 %
Net Income 10 Yeari Growth Per Share 1502.13 % 410.99 % 1502.13 % 48.51 %
Operating Income Growth 20.82 % 6.46 % 20.82 % 15.77 %
Operating Cash Flow Growth (CFG) 37.24 % 17.86 % 37.24 % 3.79 %
Operating 3 Year CFG 77.55 % -16.72 % 77.55 % 0.13 %
Operating 5 Year CFG 76.92 % 42.4 % 76.92 % 1.55 %
Operating 10 Year CFG 143.61 % 102.79 % 143.61 % 22.45 %
EPS Growth 16.55 % 134.55 % 16.55 % 31.05 %
EPS Diluted Growth 16.25 % 133.64 % 16.25 % 30.8 %
Book Value Per Share 11.25 % 23.54 % 11.25 % -1.16 %
Share Holder 3 Year Equity Growth Per Share 26.58 % 36.46 % 26.58 % -4.58 %
Share Holder 5 Year Equity Growth Per Share 48.35 % 56.53 % 48.35 % -1.29 %
Share Holder 10 Year Equity Growth Per Share 186.31 % 92.83 % 186.31 % -23.12 %
Dividend Per Share Growth -100 % 8.02 % -100 % 1.11 %
Dividend 3 Year Growth Per Share -100 % 22.8 % -100 % 10.78 %
Dividend 5 Year Growth Per Share - 72.53 % - 29.33 %
Dividend 10 Year Growth Per Share - 148.92 % - 128.74 %
Debt Growth 17.44 % -3.77 % 17.44 % 13.95 %
Free Cash Flow Growth 55.31 % 25.54 % 55.31 % -0.29 %
Updated On 31 Dec 2024 31 Dec 2024 31 Dec 2024 25 Apr 2025
Profitability
BSX-PA ABT BSX SYK MDT EW
Gross Profit Margin TTM 63.23 % 52.92 % 63.23 % 62.19 % 63.44 % 78.84 %
Return on Assets TTM 6.23 % 16.64 % 6.23 % 6.3 % 5.12 % 30.75 %
Return on Equity TTM 11.77 % 29.93 % 11.77 % 14.08 % 9.62 % 41.25 %
Return on Capital Employed TTM 8.84 % 10.76 % 8.84 % 13.86 % 7.71 % 12.32 %
Net Income Per EBT TTM 83.43 % 176.99 % 83.43 % 87.08 % 82.32 % 254.92 %
EBT Per Ebit TTM 96.68 % 103.99 % 96.68 % 61.93 % 92.49 % 109.28 %
EBIT Per Revenue TTM 16.77 % 17.62 % 16.77 % 22.72 % 17.9 % 26.19 %
Cash Flow To Debt Ratio TTM 32.56 % 67.25 % 32.56 % 25.04 % 24.98 % 113.14 %
Receivables Turnover TTM 6.87 4.21 6.87 6.08 5.46 6.3
Payables Turnover TTM 6.77 4.71 6.77 6.25 4.89 7.4
Inventory Turnover TTM 2.37 2.92 2.37 1.7 -33.52 1.05
Fixed Asset Turnover TTM 481.99 % 378.32 % 481.99 % 560.03 % -6785.71 % 311.41 %
Asset Turnover TTM 46.07 % 51.32 % 46.07 % 51.41 % 37.59 % 42.15 %
Operating Cash Flow Per Share TTM 2.58 5.19 2.58 11.22 5.58 1.35
Free Cash Flow Per Share TTM 1.94 3.89 1.94 9.36 4.14 1.04
Cash Per Share TTM 49.04 % 418.4 % 49.04 % 644.69 % 633.66 % 557.55 %
Operating Cash Flow Sales Ratio TTM 20.61 % 20.96 % 20.61 % 18 % 20.89 % 13.98 %
Free Cash Flow Operating Cash Flow Ratio TTM 75.37 % 74.97 % 75.37 % 83.42 % 74.21 % 76.48 %
Cash Flow Coverage Ratios TTM 32.56 % 67.25 % 32.56 % 25.04 % 24.98 % 113.14 %
Price To Free Cash Flows Ratio TTM 54.76 33.96 55.46 41.65 22.29 78.45
Price To Operating Cash Flows Ratio TTM 41.18 25.46 41.71 34.73 16.54 59.98
Price Cash Flow Ratio TTM 41.18 25.46 41.71 34.73 16.54 59.98
Income Statement (TTM)
BSX-PA ABT BSX SYK MDT EW
Revenue $16.75B $41.95B $16.75B $22.6B $33.54B $5.44B
Gross Profit $10.27B $21.33B $10.27B $13.98B $21.91B $4.32B
Gross Profit Ratio 61.31% 50.83% 61.31% 61.87% 65.32% 79.46%
EBITDA $3.94B $10.83B $3.94B $4.94B $9.22B $1.72B
Net Income $1.85B $13.4B $1.85B $2.99B $4.66B $4.17B
EPS Diluted 1.25 7.64 1.25 7.76 3.61 6.97
Balance Sheet (MRQ)
BSX-PA ABT BSX SYK MDT EW
Long Term Debt $9.37B $13.52B $9.37B $12.57B $25.64B $0.68B
Total Liabilities $17.39B $33.51B $17.39B $22.34B $43.42B $2.99B
Total Equity $22B $47.9B $22B $20.63B $48.26B $10.06B
Total Investments $0.56B $1.24B $0.56B $0.88B $6.75B $1.24B
Total Debt $11.15B $15.28B $11.15B $14.12B $28.52B $0.7B
Total Assets $39.4B $81.41B $39.4B $42.97B $91.68B $13.06B
Cash Flow Statement (TTM)
BSX-PA ABT BSX SYK MDT EW
Net Income $1.85B $13.4B $1.85B $2.99B $4.69B $4.17B
Inventory $-0.23B $-0.06B $-0.23B $-0.21B $-0.29B $-0.26B
Dividends Paid $0B $-3.84B $0B $-1.22B $-3.59B $0B
Operating Cash Flow $3.44B $8.56B $3.44B $4.24B $7.04B $0.54B
Capital Expenditure $-0.79B $-2.21B $-0.79B $-0.76B $-1.86B $-0.25B
Related Stocks
Ticker Name Price
ABMD Abiomed, Inc. 381.02
ABT Abbott Laboratories 132.18
ADGM Adagio Medical Holdings, Inc. 1.635
AEMD Aethlon Medical, Inc. 1.35
AFIB Acutus Medical, Inc. 0.0006
AHCO AdaptHealth Corp. 9.09
AHPI Allied Healthcare Products, Inc. 0.004
ALGN Align Technology, Inc. 132.355
ALUR Allurion Technologies Inc. 2.12
AMIX Autonomix Medical, Inc. Common Stock 1.18
ANIK Anika Therapeutics, Inc. 9.01
AORT Artivion, Inc. 43.32
APEN Apollo Endosurgery, Inc. 10
APYX Apyx Medical Corporation 1.9
ARAY Accuray Incorporated 1.46
ASXC Asensus Surgical, Inc. 0.3479
ATEC Alphatec Holdings, Inc. 15.9
AVNS Avanos Medical, Inc. 12.35
AVR Anteris Technologies Global Corp. Common Stock 4.1
AXDX Accelerate Diagnostics, Inc. 0.034
Unlock